Fasiglifam (TAK-875)

fasiglifam · Takeda

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Fasiglifam (TAK-875), covering 2010-06-11 to 2016-04-05. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 Diabetes [Phase 3]